In late March, the author came to a plasma collection station in Tongnan District, Chongqing. According to the webmaster of the station, in this plasma collection station, two or three hundred donors will donate plasma every day. The plasma they donate will be extracted through the process of collection, separation and storage, and then sent to the blood products company through quick freezing, storage and other processes.
Behind it, Chongqing Sanda Weiye Pharmaceutical Co., Ltd. is a manufacturer that provides comprehensive solutions for plasma collection for various plasma collection stations, ensuring the health and safety of plasma donors and ensuring the cleanness and effectiveness of bags of plasma.
extend the blood safety industry chain
Throughout the blood products industry chain, it can be divided into three links: upstream plasma collection stations, midstream blood products enterprises and downstream medical institutions. Among them, the upstream plasma collection station, that is, the plasma station that only collects the plasma of blood donors, is the only source of raw materials.
According to public information, in 2020, the market scale of blood products in China was about 38.2 billion yuan, an increase of 3% over 2019. Before that, the market scale of China’s blood products increased from 26.8 billion yuan in 2016 to 35 billion yuan in 2019, with an average annual compound growth rate of 9.31%. The scale of Chinese blood products industry is predicted to reach 40.5 billion yuan in 2022.
“Plasma collection is the core factor affecting the production of blood products. With the gradual elimination of the impact of the epidemic on China’s plasma collection, it is expected that China’s plasma collection stations and plasma collection volume will continue to grow.”. The managers of the three great undertakings in Chongqing said that at present, the import of blood products in China accounts for about 60%. With the rapid growth of China’s demand for blood products, the trend of independent innovation is becoming more and more obvious.
“In fact, Qingdao Haier Biomedical Co.Ltd(688139) began to lay out the blood field a few years ago. Later, in the development process of the company, it has always regarded blood safety as an important strategic transformation direction. Therefore, it has a better understanding of intelligent blood management solutions.” Qingdao Haier Biomedical Co.Ltd(688139) relevant person in charge said, “but in the process of making smart blood, we found that ensuring blood safety is not only to ensure blood safety in the process of storage, transportation and use, but also to ensure the supply safety of blood products”.
In order to help ensure the supply of domestic blood products, Qingdao Haier Biomedical Co.Ltd(688139) got acquainted with three great undertakings in Chongqing. According to public data, Chongqing’s three great undertakings are professional manufacturers designated by the state to produce medical devices and supporting drugs. They are one of the few enterprises in China with a full range of plasma collection products such as plasma collection equipment, consumables and supporting drugs. They are at the leading level in China in the field of plasma collection in the blood products industry. In 2019, China’s market share accounted for about 38%. At present, only two companies in China can provide complete plasma collection solutions.
set off a revolution in the Internet of things
“The customers of the three great undertakings in Chongqing are mainly concentrated in Chinese blood products enterprises, and the customer resources are relatively single. At the same time, the company’s channels in hospitals, blood stations and overseas markets have yet to be developed” Qingdao Haier Biomedical Co.Ltd(688139) announcement once said that it would use its own brand and channel advantages to help Chongqing’s three great undertakings develop new key customers, actively promote the business integration between Chongqing’s three great undertakings and Qingdao Haier Biomedical Co.Ltd(688139) to improve the safety of blood use and extend the product line.
Now, a revolution is being set off in the three great undertakings of Chongqing.
The first is scientific research. The management personnel of the three great undertakings in Chongqing said that there were only four people in the original R & D team. At present, the three great undertakings in Chongqing have established a scientific research team with a relatively complete R & D system. “We all share the same values, have great ideals and feelings, and hope to seize the opportunity in the field of independent innovation of domestic blood separation equipment”.
In addition, it is the marketing side, opening up hospitals, blood stations and overseas markets. It is reported that the products of Chongqing’s three great undertakings are going to the international market with the help of Qingdao Haier Biomedical Co.Ltd(688139) ‘s overseas channels. Now there are orders in Southeast Asia and Africa.
At the same time, Qingdao Haier Biomedical Co.Ltd(688139) ‘s management mode and rendanheyi culture have also been incorporated into the three great undertakings in Chongqing. The employee stock ownership plan and other incentive measures are boosting the work enthusiasm and confidence of the employees of the three great undertakings in Chongqing.
On the product side, Qingdao Haier Biomedical Co.Ltd(688139) the idea of Internet of things is being copied to the three great undertakings in Chongqing. Some products of the enterprise plan to be equipped with Internet of things modules, which will become an important part of Qingdao Haier Biomedical Co.Ltd(688139) Internet of things blood safety solution. In addition, Chongqing’s three great undertakings are investing in the construction of phase II Industrial Park, which will further significantly increase production capacity.
These changes have also boosted the three great undertakings of Chongqing at the performance level. According to public data, in 2019, the operating revenue of the three great undertakings in Chongqing was 118 million yuan and the net profit was 33.18 million yuan. Various measures have maintained the steady growth of the three great undertakings in Chongqing. In 2020, the revenue of the three great undertakings in Chongqing was 134061400 yuan, a year-on-year increase of 13.34%; Among them, the company’s revenue increased by 5.60% year-on-year from January to October before the acquisition, and 21.67% year-on-year from November to December after the acquisition. Since the integration, the speed has increased significantly, showing a good development momentum.
crack the “neck stuck” problem
It is reported that as a field related to biological products, the plasma collection industry is strictly regulated by the state and has a high qualification certification threshold. At present, the three great undertakings in Chongqing have been approved with 23 domestic drug registration certificates and 3 class III medical device registration certificates. It has become one of the leading comprehensive solution service providers for pulp collection in China, with high barriers and strong competitiveness.
“We are not only interested in the existing plasma business of the three great undertakings in Chongqing.” Qingdao Haier Biomedical Co.Ltd(688139) the relevant person in charge recalled, “we also noticed that the three great undertakings in Chongqing, formerly the school run enterprise of the Third Military Medical University, have long arranged a lot of registration licenses for medical devices and consumables. With these licenses, we can do more.”.
“At present, China’s blood products and high-end medical equipment are heavily dependent on imports.” When it comes to the neck sticking problem of blood products, the three managers in Chongqing admitted to the author.
Increasing the proportion of domestic high-end medical equipment of blood products companies and solving the problem of “neck sticking” may be the development direction of the whole medical industry in the next few years, and will also be the vision and layout of the three great undertakings of Chongqing and even the field of Qingdao Haier Biomedical Co.Ltd(688139) blood safety.
It is reported that around the mode of independent innovation and ecological co creation, relying on the three great undertakings of Chongqing and Qingdao Haier Biomedical Co.Ltd(688139) own scheme innovation and channel advantages in the field of blood safety, the company will continue to increase R & D investment in the future, tackle the problem of “neck sticking”, and realize the expansion from the scene of blood component separation to the scene of blood component preservation and blood treatment.
Now, with the completion of the three great businesses in Chongqing, Qingdao Haier Biomedical Co.Ltd(688139) ‘s smart blood ecological territory has been expanded again. With the three great undertakings of Chongqing gradually opening up new scenes in the field of blood safety, Qingdao Haier Biomedical Co.Ltd(688139) ‘s intelligent blood ecological territory can also be extended from hospitals and blood stations to plasma collection stations, so as to expand the comprehensive solution of “equipment + software + consumables + drugs”. Relevant solutions can also be applied to blood safety scenes including blood stations, hospitals and plasma collection stations.
It is reported that the follow-up two sides can not only quickly integrate the Chinese market resources of hospitals, blood stations and plasma stations, but also further explore overseas markets by increasing the construction of product certification system, so as to realize the integration of advantages and synergy and complementarity. After completing the merger and acquisition of the three great undertakings in Chongqing, the company launched the plasma single collection scenario scheme of the Internet of things, and the blood safety scenario scheme has been newly supplemented, enriching the blood safety scenario ecology.
“We hope that through the efforts of our team, we can gradually build a great wall of China’s blood safety and blood safety.”. Said the managers of the three great undertakings in Chongqing.
